EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,805,000 | +46.0% | 51,724 | +40.8% | 0.17% | +51.8% |
| Q4 2020 | $3,290,000 | -44.0% | 36,724 | -35.5% | 0.11% | -42.0% |
| Q3 2020 | $5,880,000 | +25.3% | 56,901 | -4.1% | 0.19% | +50.8% |
| Q2 2020 | $4,693,000 | +38.6% | 59,353 | +1.5% | 0.13% | +26.7% |
| Q1 2020 | $3,385,000 | +67.4% | 58,479 | +55.9% | 0.10% | +119.6% |
| Q4 2019 | $2,022,000 | -38.1% | 37,500 | -40.0% | 0.05% | -37.0% |
| Q3 2019 | $3,266,000 | -28.2% | 62,448 | -33.7% | 0.07% | -29.1% |
| Q2 2019 | $4,549,000 | -45.7% | 94,148 | -43.2% | 0.10% | -39.1% |
| Q1 2019 | $8,374,000 | -18.8% | 165,748 | -4.7% | 0.17% | -23.9% |
| Q4 2018 | $10,311,000 | +6.1% | 173,967 | +17.8% | 0.22% | +29.1% |
| Q3 2018 | $9,719,000 | +9.5% | 147,663 | -16.0% | 0.17% | +12.4% |
| Q2 2018 | $8,875,000 | +27.6% | 175,790 | +33.1% | 0.15% | +27.5% |
| Q1 2018 | $6,955,000 | +21.6% | 132,101 | +7.3% | 0.12% | +22.4% |
| Q4 2017 | $5,721,000 | +67.5% | 123,112 | +45.8% | 0.10% | +24.1% |
| Q3 2017 | $3,415,000 | +58.4% | 84,433 | +32.8% | 0.08% | +51.9% |
| Q2 2017 | $2,156,000 | +16.7% | 63,591 | -0.1% | 0.05% | +13.0% |
| Q1 2017 | $1,848,000 | -11.6% | 63,634 | 0.0% | 0.05% | -17.9% |
| Q4 2016 | $2,090,000 | +4.0% | 63,634 | -0.1% | 0.06% | -3.4% |
| Q3 2016 | $2,009,000 | -21.8% | 63,696 | -30.3% | 0.06% | -24.7% |
| Q2 2016 | $2,570,000 | -10.7% | 91,369 | +15.4% | 0.08% | -11.5% |
| Q1 2016 | $2,878,000 | -15.1% | 79,169 | -6.5% | 0.09% | -9.4% |
| Q4 2015 | $3,389,000 | +37.1% | 84,715 | -2.3% | 0.10% | +29.7% |
| Q3 2015 | $2,472,000 | -15.5% | 86,726 | -2.3% | 0.07% | -14.9% |
| Q2 2015 | $2,924,000 | +5.2% | 88,726 | -8.2% | 0.09% | +2.4% |
| Q1 2015 | $2,779,000 | +4.4% | 96,637 | -1.2% | 0.08% | -9.6% |
| Q4 2014 | $2,662,000 | +27.1% | 97,763 | -0.5% | 0.09% | +22.1% |
| Q3 2014 | $2,094,000 | -1.5% | 98,243 | +3.8% | 0.08% | -3.8% |
| Q2 2014 | $2,126,000 | -28.4% | 94,637 | -19.5% | 0.08% | -33.9% |
| Q1 2014 | $2,971,000 | +241.1% | 117,515 | +210.2% | 0.12% | +227.0% |
| Q4 2013 | $871,000 | – | 37,880 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |